期刊文献+

HBV PreS2-MBP融合蛋白在大肠杆菌中表达条件的优化 被引量:4

Optimization of Condition for Expression of HBV PreS2-MBP Fusion Protein in E. coli
下载PDF
导出
摘要 目的优化HBV PreS2-MBP融合蛋白在大肠杆菌中的表达条件。方法通过改变重组质粒的宿主菌、培养基、诱导温度、诱导剂、诱导剂浓度、诱导时间等条件,利用SDS-PAGE和BandScan凝胶分析软件,分析以上条件改变对表达产物表达量的影响。将重组质粒连续传100代,检测融合蛋白的表达稳定性。结果重组质粒在大肠杆菌BL21菌株、GS培养基、28℃、0.5mmol/L IPTG或1.5mmol/L乳糖诱导4h时,目的蛋白的表达量最高,占菌体总蛋白的43.5%。重组质粒传代100代,融合蛋白的表达稳定。结论已确定出了融合蛋白在大肠杆菌中表达的最佳条件。 Objective To optimize the condition for expression of HBV PreS2-MBP fusion protein in E. coli. Methods Analyze the influence of host bacterium,culture medium,temperature and time for induction as well as inducer and its concentration on expression level of HBV PreS2-MBP fusion protein in E. coli by SDS-PAGE and BandScan software. Subculture recombinant E. coli strain for 100 passages and test the expression stability of HBV PreS2-MBP fusion protein. Results The expression level of HBV PreS2-MBP fusion protein reached 43.5% of total somatic protein in E. coli BL21 strain cultured in GS medium under induction of 0. 5 mmol/L IPTG or 1.5 mmol/L lactose at 28℃ for 4 h. The expression level of fusion protein in E. coli BL21 strain subcultured for 100 passages showed no significant difference with that in original strain. Conclusion The condition for expression of HBV PreS2-MBP fusion protein in E. coli was optimized.
出处 《中国生物制品学杂志》 CAS CSCD 2007年第6期435-438,共4页 Chinese Journal of Biologicals
关键词 HBV PreS2-MBP融合蛋白 大肠杆菌 表达条件 HBV PreS2-MBP fusion protein E, coli Expression condition
  • 相关文献

参考文献12

二级参考文献23

共引文献31

同被引文献42

  • 1周宇荀,曹巍,魏东芝,罗清平,王锦之.抗菌肽Adenoregulin基因工程菌培养条件的优化及分批发酵研究[J].生物工程学报,2005,21(4):615-621. 被引量:14
  • 2李彦杰,王保莉,张守涛,郭蔼光.人基质蛋白酶2(MMP-2)类血红素结构域原核表达优化[J].西北农业学报,2006,15(2):109-111. 被引量:1
  • 3董燕,王捷,谭刘欣,张宏斌,武婕.重组人骨唾液酸蛋白的纯化及生物学活性研究[J].中国生化药物杂志,2006,27(2):71-74. 被引量:3
  • 4余光清,蒋诗琴,李雍龙.可溶性重组日本血吸虫26 kDa GST的优化表达[J].中国人兽共患病学报,2006,22(8):770-773. 被引量:10
  • 5SnowRW, Guerra CA, Noor AM,et al. The global distribution of clinical episodes of PIasmodium falciparum malaria [ J ]. Nature 2005,434 (7030) :214- 217.
  • 6Cai QL, Wei F, Lin YH, et al. Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria [ J ]. Vaccine 2004,23(2) : 267- 277.
  • 7Cai QL, Peng G, Bu L, et al. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling [ J ]. Vaccine 2007,25 (28) : 5155- 5165.
  • 8Zhou Z, Todd CW, Wohlhueter RM, et al. Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen ( FALVAC-1 A) expressed in Escherichia coli[J]. Hum Vaccin 2006,2(1 ) : 14- 23.
  • 9Dipti CA, Jain SK, Navin K. A novel recombinant multiepitope protein as a hepatitis C diagnostic intermediate of high sensitivity and specificity[J]. Protein Expr Purif 2006, 47(1) : 319- 328.
  • 10Sambrook J,Russell D.分子克隆实验指南.3版.黄培堂,译.北京:科学出版社,2002.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部